1.620USD-2.41%Mkt Cap: 68.21M USDP/E: —Last update: 2026-06-01
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobr…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap68.21M USD
Enterprise Value64.41M USD
Revenue (TTM)88.55M USD
Gross Profit67.14M USD
Net Income (TTM)-54.00M USD
Revenue/Share2.151 USD
Last Price1.620 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees296
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS7458481014
Valuation
P/E (Trailing)—
P/E (Forward)-1.58
PEG—
EV/EBITDA-1.26
EV/Revenue0.73
P/S0.79
P/B1.52
EPS (TTM)-1.30
EPS (Forward)-1.04
52W Range
1.13018% of range3.880
52W High3.880 USD
52W Low1.130 USD
Profitability
Gross Margin74.19%
Oper. Margin-62.94%
EBITDA Margin-57.78%
Profit Margin-59.67%
ROE-99.79%
ROA-41.77%
Growth
Revenue Growth-8.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-32.38M USD
CapEx (TTM)452.00K USD
FCF Margin-9.44%
FCF Yield-12.26%
Net Debt-5.28M USD
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity1.04
Current Ratio4.91
Quick Ratio3.85
Book Value/Sh1.083 USD
Cash/Share1.458 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)3.400 USD
Target Range2.500 USD – 5.000 USD
# Analysts5
Ownership
Shares Out.42.24M
Float37.27M
Insiders4.66%
Institutions79.14%
Short Interest
Short Ratio5.1d
Short % Float7.59%
Short % Out.6.39%
Shares Short2.70M
Short (prev mo.)2.81M
Technical
SMA 501.353 (+19.8%)
SMA 2001.669 (-3.0%)
Beta0.18
S&P 52W Chg27.94%
Avg Vol (30d)500.43K
Avg Vol (10d)417.35K
Technical Indicators
RSI (14)71.4
MACD0.0702
MACD Signal0.0327
MACD Hist.+0.0375
BB Upper1.671 USD
BB Middle1.397 USD
BB Lower1.124 USD
BB Width39.09%
ATR (14)0.0971 USD
Vol Ratio (20d)0.41x